Abstract:Background: Silibinin (Sil), a flavonoid lignan-like natural compound derived from milk thistle seeds, has been used to treat hepatic diseases, including early-phase hepatocirrhosis and fatty liver, for many years. However, its poor water solubility limits its gastrointestinal absorption and bioavailability. It clinical use has been limited due to its slow onset of action. Faced with this problem, research on the derivatives of silibinin has been receiving much attention. Purpose: A series of silibinin derivatives with good biosafety and higher hepatoprotective activity were obtained by a safe, efficient and green chemical synthesis method. Patients and methods: First, the carbonyl group in the structure of silibinin was used to obtain silibinin Schiff base derivatives by dehydration condensation with the carboxyl group in the sulfur-containing amino acid. Next, relevant experiments were performed to characterize the structure, physical form and solubility of the derivatives. Then, toxicity tests of the derivatives were performed in LO-2 cells and SD rats to evaluate their biosafety. Finally, the anti-inflammatory and antiapoptotic activities were observed using a carbon tetrachloride (CCl4)-induced acute liver injury model in C57BL/6J mice using silibinin as a control. Results: The studies showed that SS and ST behaved as amorphous substances and showed a significant increase in solubility compared to silibinin. These two derivatives showed low toxicity in biosafety tests and higher bioactivity (anti-inflammatory and anti-apoptotic) than silibinin against acute liver injury induced by CCl4. Conclusion: Two silibinin derivatives (SS and ST) obtained by the Schiff base reaction improved the solubility of the silibinin parent nucleus in biological media with the help of the hydrophilic and amorphous morphology of the ligand. The low toxicity in vivo and in vitro ensures the biosafety of the derivatives. The hepatoprotective activity (anti-inflammatory and anti-apoptotic) was significantly improved compared to silibinin.

Preparation of C-23 Esterified Silybin Derivatives and Evaluation of Their Lipid Peroxidation Inhibitory and DNA Protective Properties

Preparation of Silybin 23-Esters and Evaluation of Their Inhibitory Ability Against LPO and DNA Protective Properties

Synthesis and Antioxidant Evaluation of Novel Silybin Analogues

Synthesis and Antioxidant Properties of Novel Silybin Analogues

Synthesis and Antioxidant Activities of Silybin Ester of N-Carbobenzyloxyglycine

Synthesis,Characterization and Antioxidant Activity of Silybin Lactosified Derivatives

Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin.

Design, Synthesis, and Examination of Neuron Protective Properties of Alkenylated and Amidated Dehydro-Silybin Derivatives

Free Radical Scavenging Reactions and Antioxidant Activities of Silybin: Mechanistic Aspects and Pulse Radiolytic Studies

Preparation and Effects of 2,3-Dehydrosilymarin, a Promising and Potent Antioxidant and Free Radical Scavenger.

7-O-tyrosyl Silybin Derivatives as a Novel Set of Anti-Prostate Cancer Compounds

Selective Synthesis of 3-O-Palmitoyl-Silybin, a New-to-Nature Flavonolignan with Increased Protective Action against Oxidative Damages in Lipophilic Media

Mechanism-Based Inhibitory and Peroxisome Proliferator-Activated Receptor Α–dependent Modulating Effects of Silybin on Principal Hepatic Drug-Metabolizing Enzymes

In vivo evaluation of silybin nanosuspensions targeting liver.

Free‐radical Scavenging Activities of Silybin and Its Analogues: A Pulse Radiolysis Study

Silymarin Glyceryl Monooleate/Poloxamer 407 Liquid Crystalline Matrices: Physical Characterization and Enhanced Oral Bioavailability

Protective Effects of Silybin and Analogues Against X-ray Radiation-Induced Damage

Silibinin Schiff Base Derivatives Counteract CCl4-Induced Acute Liver Injury by Enhancing Anti-Inflammatory and Antiapoptotic Bioactivities

Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization

Synthesis and antitumor activity of novel silibinin and 2,3-dehydrosilybin derivatives with carbamate groups

The Preparation of Silybin–phospholipid Complex and the Study on Its Pharmacokinetics in Rats